MELEVODOPA Drug Record

  • MELEVODOPA chembl:CHEMBL1328898

    Alternate Names:

    CHF-1301
    MELEVODOPA

    Drug Info:

    FDA Approval approved
    Drug Class Small molecule
    Drug Indications antiparkinson agent
    (0 More Sources)

    Publications:

  • MELEVODOPA   DRD5

    Interaction Score: 0.68

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name V-1512, CHF-1512,Levomet Complex, Sirio
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • MELEVODOPA   ARSA

    Interaction Score: 0.42

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MELEVODOPA   DRD4

    Interaction Score: 0.21

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name V-1512, CHF-1512,Levomet Complex, Sirio
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • MELEVODOPA   DRD3

    Interaction Score: 0.14

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name V-1512, CHF-1512,Levomet Complex, Sirio

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • MELEVODOPA   DRD1

    Interaction Score: 0.06

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name V-1512, CHF-1512,Levomet Complex, Sirio
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • MELEVODOPA   DRD2

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name V-1512, CHF-1512,Levomet Complex, Sirio

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • MELEVODOPA   HSD17B10

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TdgClinicalTrial: MELEVODOPA

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiparkinson agent
    Drug Class Small molecule
    FDA Approval approved

    Publications:

  • DTC: MELEVODOPA

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL1328898 ChEMBL Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1328898

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: